Concepedia

Amin Li

AL

Statistics

Publications

19

Citations

577

H-Index

17

Active since

2013

Affiliations

Anhui University of Science and Technology(Current)

Second People’s Hospital of Huai’an

Xuzhou Medical College

Guangzhou Medical University

First Affiliated Hospital of Bengbu Medical College

Amin Li is an author at Anhui University of Science and Technology specializing in pharmacology, oncology, and medicine.

ORCID

Publications per year

2013–2022

19

Publications

19

Anti-GPC3 antibody-modified sorafenib-loaded nanoparticles significantly inhibited HepG2 hepatocellular carcinoma

Xiaolong Tang, Longzhou Chen, Amin Li et al. · Drug Delivery · 2018 · 63 citations · Full text

, , +17

Enhanced delivery of sorafenib with anti-GPC3 antibody-conjugated TPGS-b-PCL/Pluronic P123 polymeric nanoparticles for targeted therapy of hepatocellular carcinoma

Huaiyong Gan, Longzhou Chen, Xuemei Sui et al. · Materials Science and Engineering C · 2018 · 55 citations

, , +16

PKI-587 enhances chemosensitivity of oxaliplatin in hepatocellular carcinoma through suppressing DNA damage repair pathway (NHEJ and HR) and PI3K/AKT/mTOR pathway.

Yinci Zhang, Chunmei Xie, Amin Li et al. · PubMed · 2019 · 44 citations

, , +17

Curcumin reverses hepatic epithelial mesenchymal transition induced by trichloroethylene by inhibiting IL-6R/STAT3

Weiya Cao, Yinci Zhang, Amin Li et al. · Toxicology Mechanisms and Methods · 2021 · 42 citations

, , +17

LY3214996 relieves acquired resistance to sorafenib in hepatocellular carcinoma cells

Yongfang Ma, Ruyue Xu, Xueke Liu et al. · International Journal of Medical Sciences · 2021 · 38 citations · Full text

, , +17

1–5 of 19